Document Details
Form
Filing Date
Aug 26, 2020
Document Date
Aug 26, 2020
Form Description
Draft registration statement submitted by Emerging Growth Company under Securities Act Section 6(e) or by Foreign Private Issuer under Division of Corporation Finance policy
Filing Group
Registration Statements
Company
Aligos Therapeutics
Issuer
Aligos Therapeutics, Inc.
